Literature DB >> 7104963

Bilateral breast cancer in patients with initial stage I and II disease.

S R Schell, E D Montague, W J Spanos, N D Tapley, G H Fletcher, M J Oswald.   

Abstract

Between January 1947 and the end of 1975, of 2076 patients with Stages I and II breast cancer treated at M. D. Anderson Hospital, 126 received treatment for cancer in both breasts. Records of 94 patients who had only one cancer treated at U. T. M. D. Anderson Hospital and in whom staging and treatment details were not available and records of the patients who developed local, regional, or systemic failure prior to diagnosis of the second breast were excluded. Of 126 patients with bilateral breast cancer, 39 had simultaneous tumor (both cancers diagnosed within six months) and 87 had consecutive tumors. The disease-free 20-year survival rate shows no significant difference between patients with unilateral tumors and those with bilateral simultaneous or consecutive tumors. Analysis by radiotherapy modality or surgery alone shows, if anything, a lower incidence of cancer in the second breast in the irradiated patients, indicating that in patients with Stage I or Stage II lesions, the doses of radiation given in the management of the first breast cancer were not conducive to the development of a cancer in the remaining breast.

Entities:  

Mesh:

Year:  1982        PMID: 7104963     DOI: 10.1002/1097-0142(19820915)50:6<1191::aid-cncr2820500628>3.0.co;2-f

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  The role of mammography in the detection of bilateral primary breast cancer.

Authors:  J G Tinnemans; T Wobbes; J H Hendriks; R Holland; R F Van der Sluis; H H De Boer
Journal:  World J Surg       Date:  1988-06       Impact factor: 3.352

2.  Bilateral breast cancer: one disease or two?

Authors:  P J Dawson; T Maloney; P Gimotty; P Juneau; H Ownby; S R Wolman
Journal:  Breast Cancer Res Treat       Date:  1991-11       Impact factor: 4.872

3.  Dosimetric advantages of generalised equivalent uniform dose-based optimisation on dose-volume objectives in intensity-modulated radiotherapy planning for bilateral breast cancer.

Authors:  T-F Lee; H-M Ting; P-J Chao; H-Y Wang; C-S Shieh; M-F Horng; J-M Wu; S-A Yeh; M-Y Cho; E-Y Huang; Y-J Huang; H-C Chen; F-M Fang
Journal:  Br J Radiol       Date:  2012-11       Impact factor: 3.039

Review 4.  The role of post-operative radiotherapy in the treatment of operable breast cancer.

Authors:  G F Beadle; J R Harris
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

Review 5.  Adjuvant dietary fat intake reduction in postmenopausal breast cancer patient management. The Women's Intervention Nutrition Study (WINS).

Authors:  R T Chlebowski; D Rose; I M Buzzard; G L Blackburn; W Insull; M Grosvenor; R Elashoff; E L Wynder
Journal:  Breast Cancer Res Treat       Date:  1992-01       Impact factor: 4.872

6.  Primary bilateral breast cancer.

Authors:  E B Smith
Journal:  J Natl Med Assoc       Date:  1986-11       Impact factor: 1.798

7.  Bilateral breast carcinoma: 28 years' experience.

Authors:  H Gülay; E Hamaloğlu; O Bulut; H A Göksel
Journal:  World J Surg       Date:  1990 Jul-Aug       Impact factor: 3.352

8.  Prognostic significance of synchronous and metachronous bilateral breast cancer.

Authors:  J Kollias; I O Ellis; C W Elston; R W Blamey
Journal:  World J Surg       Date:  2001-09       Impact factor: 3.352

9.  Bilateral breast cancer in northern Alberta: risk factors and survival patterns.

Authors:  P E Burns; K Dabbs; C May; A W Lees; L R Birkett; H J Jenkins; J Hanson
Journal:  Can Med Assoc J       Date:  1984-04-01       Impact factor: 8.262

10.  Bilateral breast cancer. Risk reduction by contralateral biopsy.

Authors:  H J Wanebo; G M Senofsky; R E Fechner; D Kaiser; S Lynn; J Paradies
Journal:  Ann Surg       Date:  1985-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.